Neurology Digital Health Market (2026-2036)
The global neurology digital health market was valued at USD 59.8 billion in 2026. This market is expected to reach USD 421.8 billion by 2036, growing at a CAGR of 21.6% during the forecast period 2026–2036.
- Published
- Jun 2026
- Pages
- 281
- Format
- PDF + Excel
- Report ID
- MRHC - 1042025
- Base year
- 2025
- 2026 · ESTIMATED
- $59.80B
- 2036
- $421.8B
- CAGR 2026–2036
- 21.6%
2025 baseline · 2026–2036 forecast at 21.6% CAGR · hover a bar for the value
Key highlights
The global neurology digital health market is projected to reach USD 421.8 billion by 2036.
The market is expected to grow at a CAGR of 21.6% during the forecast period 2026–2036.
The global market is estimated at USD 59.8 billion in 2026.
Tele-neurology currently holds the largest technology share due to global specialist shortages.
AI in neurology is the fastest-growing technology segment, improving diagnostic speed and accuracy.
Neurological disorders are the leading cause of disability-adjusted life years (DALYs) globally.
The total global cost of neurological disorders was estimated at USD 3.3 trillion in 2021.
North America holds the largest market share, estimated at approximately 45% in 2026.
Pharmaceutical and biotech companies are the fastest-growing end-user segment for digital neurology tools.
Report summary
| Particulars | Details |
|---|---|
| Base Year | 2025 |
| Estimated Year | 2026 |
| Forecast Period | 2026–2036 |
| Market Size (2026) | USD 59.80 billion |
| Market Size (2036) | USD 421.80 billion |
| CAGR (2026–2036) | 21.6% |
| Format | PDF, Excel & Cloud Portal · 281 pages |
| Segments Covered | By Technology: Tele-neurology, AI & Data Analytics · By Component: Software, Hardware, Services · By Application · By End User: Hospitals, Pharma & Biotech, Homecare |
| Key Companies | Medtronic plc, Philips Healthcare, GE HealthCare, Siemens Healthineers, Abbott Laboratories, Biogen, Roche, Akili, Inc., Cogstate Ltd., Linus Health, Rune Labs, NeuroTrack Technologies, Click Therapeutics, MindMaze, Hinge Health, Empatica, Beacon Biosignals, Ceribell, Inc |
Report infographic
Market dynamics
7 factors across 4 forcesThe primary driver for the neurology
digital health market is the rising global prevalence of chronic neurological disorders. According to the World Health Organization, neurological conditions affect more than 3 billion people worldwide and are currently the leading cause of ill health and disability globally. Furthermore, more than 55 million people are living with dementia worldwide, and this number is projected to increase to approximately 139 million by 2050, driven largely by population aging. The growing burden of neurological diseases is creating an urgent need for scalable digital neurology solutions that support early detection, continuous monitoring, and long-term disease management.
Furthermore, advancements in AI and machine
learning are enabling the analysis of complex neurological data, making digital health in neurology more reliable and actionable. The shift toward decentralized clinical trials by pharmaceutical companies is also a major driver, as digital tools allow for more frequent and accurate patient data collection.
A significant restraint is the inherent complexity of neurological data,
where high variability in patient symptoms across conditions like Alzheimer’s and Parkinson’s makes standardized digital interventions difficult to implement. Additionally, regulatory hurdles for AI-based diagnostics and digital therapeutics remain high. The FDA and EMA require stringent clinical evidence for software-as-a-medical-device (SaMD) clearance, which can slow the time to market for innovative neurological health technology. The sensitive nature of brain health data also presents significant privacy and security concerns that must be addressed to gain broad patient and provider trust.
Table of contents
12 chapters · 114 sections · 281 pages · click to expandSegmental analysis
| Segment | Largest share (2026) | Fastest growth (2026–2036) |
|---|---|---|
| By Technology | Tele-neurology | AI & Data Analytics |
| By Application | Neurodegenerative Disorders | Epilepsy & Seizure Management |
By Technology
- Tele-neurology to Hold Largest Share
- The Tele-neurology segment is expected to hold the largest share of the market.
- This is primarily due to the global shortage of neurologists and the rapid establishment of virtual care infrastructure during the COVID-19 pandemic, which has now become a standard of care.
- The AI & Data Analytics segment is projected to witness the fastest growth, driven by the critical need for automated neuroimaging analysis and the increasing volume of longitudinal data from remote monitoring platforms.
By Application
- Neurodegenerative Disorders to Lead
- The Neurodegenerative Disorders segment is expected to hold the largest share.
- Conditions like Alzheimer’s and Parkinson’s represent the largest and most costly long-term care burden in neurology.
- The Epilepsy & Seizure Management segment is projected to witness the fastest growth, as patients and caregivers increasingly adopt real-time remote monitoring and logging tools to improve safety and treatment adherence.
Geographic analysis
North America
Largest shareNorth America is expected to hold the largest share of the global neurology digital health market in 2026, accounting for approximately 45% of total revenue. This dominance is driven by the region's advanced digital infrastructure, high concentration of leading health-tech firms, and favorable regulatory and reimbursement environments for digital therapeutics and remote monitoring.
Asia-Pacific
Fastest growthAsia-Pacific is projected to witness the fastest growth during the forecast period. The region's aging population, particularly in Japan and China, is creating massive demand for brain health technology. Furthermore, the rapid digitization of healthcare systems in China and India is facilitating the broad rollout of tele-neurology and AI-driven diagnostic tools. Key companies operating in the Asia-Pacific market include global leaders and a growing number of local AI-focused startups.
Competitive landscape
- Medtronic plc
- Philips Healthcare
- GE HealthCare
- Siemens Healthineers
- Abbott Laboratories
- Biogen
- Roche
- Akili, Inc.
- Cogstate Ltd.
- Linus Health
- Rune Labs
- NeuroTrack Technologies
- Click Therapeutics
- MindMaze
- Hinge Health
- Empatica
- Beacon Biosignals
- Ceribell, Inc
Frequently asked questions
The market is projected to reach USD 421.8 billion by 2036, growing at a CAGR of 21.6% from 2026 to 2036.
Cite this report
Meticulous Research. (2026). Neurology Digital Health Market - Global Opportunity Analysis and Industry Forecast (2026-2036) (Report No. MRHC - 1042025). Meticulous Market Research Pvt. Ltd. https://www.meticulousresearch.com/product/neurology-digital-health-market-6708